Oral pharmaceutical composition for preventing or treating dry eye syndrome comprising rebamipide or a prodrug thereof
US11712414B2 · kind B2 · utility
0Cited by
4References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 17, 2014 |
| Grant date | Aug 1, 2023 |
| Priority date | — |
| Expiry date | Apr 17, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is an oral pharmaceutical composition for preventing or treating dry eye syndrome, which comprises rebamipide or a prodrug thereof, or a pharmaceutically acceptable salt thereof, as an active ingredient. The compounds can treat dry eye syndrome via oral route, and can be thus employed safely and conveniently compared to conventional eye drops.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.